Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 28 resources
-
A peer-based needle exchange service in London
Funded by Hackney Council as part of the ADDER (addiction, diversion, disruption, enforcement and recovery) Accelerator project, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) have a released a report exploring the feasibility, acceptability, and practical considerations of developing a peer-based needle exchange service. It draws on focus groups with people who use needle exchange services and peer support workers, interviews with experts from services and commissioning bodies, and international evidence.Greater London 18 Jan 2022 Reports & Research PDF -
Hepatitis C testing and treatment interventions for the homeless population in London during the Covid-19 pandemic: Outcomes and learning
This report from the London Joint Working Group on Substance Use and Hepatitis C outlines the outcomes and learnings of hepatitis C testing and treatment interventions for the homeless population during the Covid-19 pandemic. The report reveals that over 1,000 people were tested for blood-borne viruses over the course of 98 testing events in London between May and August 2020. Of those tested, 11% were positive for hepatitis C antibodies and 7% had an active infection.England, Greater London 17 Dec 2020 Reports & Research PDF -
Routemap to eliminating hepatitis C in London: The Opportunity
On 2nd March 2020, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) launched a 'Routemap to eliminating hepatitis C in London'. This document sets out the opportunities for improving hepatitis C care in London, based around five pillars of improvement: reducing stigma; engaging people who are under-served by traditional health systems; working with GPs to find the undiagnosed; reducing pathway attrition; aligning hepatitis C and HIV public health efforts.UK, Greater London Reports & Research, Strategy & Planning PDF -
Hepatitis C in London: 2019 report
This report from Public Health England provides an update on the recent epidemiology of hepatitis C in London. Among the report's statistics are an estimate that 63% of people who inject drugs (PWID) in London had ever been infected with hepatitis C in 2018, with 41% of those ever infected having a current hepatitis C infection. It is estimated that 18% of PWID were unaware of their infection (lower than the 35% unaware in England as a whole). In 2017/18, 87% of eligible clients of drug treatment services received a hepatitis C test, a small increase from 86% in 2016/2017.England, Greater London 17 Feb 2020 Reports & Research PDF -
Summary report: Hepatitis C good practice roadshow, West London - September 2019
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England with the West London ODN on 27th September 2019. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.UK, England, Greater London 22 Oct 2019 Training, Reports & Research PDF -
HCV Action and Public Health England hepatitis C good practice roadshow, West London: Presentations
On 27th September 2019, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow with the West London ODN. The event featured presentations on progress in tackling hepatitis C, nationally and locally, and examples of best practice in the prevention, diagnosis, testing and treatment of hepatitis C.UK, England, Greater London 07 Oct 2019 Training, Strategy & Planning PDF -
HCV testing in NSP (Needle and Syringe Provision) Community Pharmacies Pilot (Phase 2)
This report from the London Joint Working Group on Substance Use and Hepatitis C (LJWG) shows the findings from a pilot project providing point of care testing for hepatitis C to people who inject drugs accessing needle and syringe programmes based at community pharmacies in London. Of the 66 people who accepted a test, 39% were hepatitis C RNA positive. 78% of those tested also stated they would prefer to receive HCV treatment in their community pharmacy.UK, Greater London Reports & Research PDF -
Joining the dots: Linking pathways to hepatitis C diagnosis and treatment
This report from the London Joint Working Group on Substance Use and Hepatitis C explores how effective data sharing can lead to quicker, easier access to care for people with hepatitis C. From interviews with various stakeholders, two main barriers to effective data sharing are identified: (1) confusion about who data can be shared with and under what circumstances, (2) a lack of computer systems that enable care providers to easily share patient data.England, Greater London Reports & Research PDF -
EMCDDA on models of care for hepatitis C in drugs services
The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF -
HCV testing in NSP (Needle and Syringe Provision) Community Pharmacies Pilot (Phase 1)
This report from the London Joint Working Group on Substance Use and Hepatitis C (LJWG) provides results from a pilot project providing point of care testing for hepatitis C to people who inject drugs accessing needle and syringe programmes based at community pharmacies in London. Over half of participants tested positive for hepatitis C antibodies and 78% of those engaging with further assessment in secondary care had chronic hepatitis C and were hepatitis C RNA positive.England, Greater London Reports & Research PDF